WST Earnings & Financial Statements
West Pharmaceutical Services, Inc.
$361.74
-$4.74(-1.29%)
55
Overall
50
Value
66
Tech
50
Quality
Market Cap
$26.22B
Volume
172.83K
52W Range
$223.83 - $386.00
Target Price
$403.71
WST earnings and financial statements: West Pharmaceutical Services, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
WST Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.07B | $2.89B | $2.95B | $2.89B | $2.83B |
| Cost of revenue | $1.97B | $1.89B | $1.82B | $1.75B | $1.66B |
| Operating income | $584.90M | $569.90M | $676.00M | $734.00M | $752.30M |
| EBITDA | $787.20M | $758.60M | $862.00M | $829.10M | $879.40M |
| Net income | $493.70M | $492.70M | $593.40M | $585.90M | $661.80M |
| EPS (diluted) | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $4.27B | $3.64B | $3.83B | $3.62B | $3.31B |
| Total liabilities | $1.09B | $961.10M | $948.50M | $931.90M | $978.40M |
| Shareholders’ equity | $3.18B | $2.68B | $2.88B | $2.68B | $2.34B |
| Cash and equivalents | $791.30M | $484.60M | $853.90M | $894.30M | $762.60M |
| Long-term debt | $298.40M | $284.40M | $157.30M | $299.70M | $271.80M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $754.80M | $653.40M | $776.50M | $724.00M | $584.00M |
| Capital expenditure | -$285.90M | -$377.00M | -$362.00M | -$284.60M | -$253.40M |
| Free cash flow | $468.90M | $276.40M | $414.50M | $439.40M | $330.60M |
| Dividends paid | $61.20M | $59.10M | $57.00M | $54.10M | $51.10M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WST | $361.74 | -1.3% | 172.83K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get West Pharmaceutical Services, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW